Aberrant Splicing in PKD2 in a Family of Korean Patients With Autosomal Dominant Polycystic Kidney Disease. [PDF]
Yoon SY, Kim JS, Park KS.
europepmc +1 more source
Inflammatory Cytokine Levels in Patients with Autosomal Dominant Polycystic Kidney Disease. [PDF]
Arjune S+8 more
europepmc +1 more source
Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review. [PDF]
Ebrahimi N+8 more
europepmc +1 more source
Incidental renal cell carcinoma post bilateral nephrectomy in autosomal dominant polycystic kidney disease. [PDF]
Shin MH, Choi NK.
europepmc +1 more source
Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities. [PDF]
Hammond S+6 more
europepmc +1 more source
EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease. [PDF]
Lv J+10 more
europepmc +1 more source
Sarcomatoid Urothelial Carcinoma Arising in Autosomal Dominant Polycystic Kidney Disease: A Case Report and Literature Review. [PDF]
Bolous Y+5 more
europepmc +1 more source
Related searches:
Autosomal dominant polycystic kidney disease
The Lancet, 1992Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes.
V. Torres, P. Harris, Y. Pirson
semanticscholar +5 more sources
Autosomal dominant polycystic kidney disease
The Lancet, 2019Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one of the most common causes of end-stage kidney disease. Multiple clinical manifestations, such as enlarged kidneys filled with growing cysts, hypertension, and multiple extrarenal complications, including liver cysts, intracranial aneurysms, and ...
E. Gall, Ahsan Alam, R. Perrone
semanticscholar +3 more sources